Tag: Food & Drug Administration
FDA Approves Balloon Device to Treat Obesity
Inflated in stomach, it may create sense of fullness
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
Delays Noted in the Reporting of Serious Patient Harms to FDA
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
FDA Approves Test to Differentiate HIV Viruses
Among people two years and older
FDA Approves Technivie for Hepatitis C
For people with chronic hepatitis C genotype 4
FDA Approves Odomzo for Recurring Basal Cell Carcinoma
Medication is designed to inhibit the Hedgehog pathway
FDA Approves Novel Leg Prosthesis for AKAs
New device adheres to the leg with fixtures and screws implanted into the remaining thigh bone
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
FDA Approves Entresto for Heart Failure
Medication helps reduce the rate of cardiovascular death, hospitalization
